{"schema_version":"secwatch.filing_event.v1","accession":"0000313616-24-000188","form_type":"8-K","ticker":"DHR","cik":"0000313616","company_name":"DANAHER CORP /DE/","filed_at":"2024-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.472564+00:00","generated_at":"2026-05-31T18:14:01.939878+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Danaher Q2 revenue down 3% to $5.7B, adjusted EPS $1.72 beats expectations","bullets":["Net earnings $907M, GAAP diluted EPS $1.22; non-GAAP adjusted EPS $1.72.","Revenue $5.7B, down 3.0% YoY; non-GAAP core revenue down 3.5%.","Operating cash flow $1.4B, free cash flow $1.1B.","CEO cites sustained momentum in bioprocessing and Cepheid market share gains.","Q3 and FY 2024 core revenue guided down low-single digits YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0000313616-24-000188","json":"https://secwatch.observer/filing/0000313616-24-000188.json","markdown":"https://secwatch.observer/filing/0000313616-24-000188.md","text":"https://secwatch.observer/filing/0000313616-24-000188.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313616/000031361624000188/0000313616-24-000188-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313616/000031361624000188/dhr-20240723.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T18:14:01.939878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}